MY181007A - Scale drop disease (sdd) causative virus and derivatives thereof - Google Patents
Scale drop disease (sdd) causative virus and derivatives thereofInfo
- Publication number
- MY181007A MY181007A MYPI2015002848A MYPI2015002848A MY181007A MY 181007 A MY181007 A MY 181007A MY PI2015002848 A MYPI2015002848 A MY PI2015002848A MY PI2015002848 A MYPI2015002848 A MY PI2015002848A MY 181007 A MY181007 A MY 181007A
- Authority
- MY
- Malaysia
- Prior art keywords
- virus
- sdd
- derivatives
- scale drop
- causative virus
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/00021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/00022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/00034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/00051—Methods of production or purification of viral material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/00061—Methods of inactivation or attenuation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/00061—Methods of inactivation or attenuation
- C12N2710/00063—Methods of inactivation or attenuation by chemical treatment
Abstract
The present invention relates to an isolated virus causing Scale Drop Disease in fish, to cell cultures comprising said virus, to vaccines on the basis of said virus and methods for the preparation of such a vaccine, to antibodies reactive with said virus, to diagnostic test kits for the detection of that virus and to uses of said virus.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP13170063 | 2013-05-31 |
Publications (1)
Publication Number | Publication Date |
---|---|
MY181007A true MY181007A (en) | 2020-12-15 |
Family
ID=48536728
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MYPI2015002848A MY181007A (en) | 2013-05-31 | 2014-05-28 | Scale drop disease (sdd) causative virus and derivatives thereof |
Country Status (5)
Country | Link |
---|---|
CN (2) | CN110438090B (en) |
AU (1) | AU2014273183B2 (en) |
MY (1) | MY181007A (en) |
SG (1) | SG11201509830UA (en) |
WO (1) | WO2014191445A1 (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2018029301A1 (en) | 2016-08-11 | 2018-02-15 | Intervet International B.V. | Novel fish pathogenic virus |
CN108315487B (en) * | 2018-04-16 | 2021-06-22 | 福建省农业科学院生物技术研究所 | Primer group and kit for detecting eel herpesvirus and application of primer group and kit |
CN111621550B (en) * | 2020-06-18 | 2021-08-10 | 中国水产科学研究院黄海水产研究所 | RPA reaction system suitable for rapid detection of mermaid subspecies of mermaid photobacterium |
CN114106112B (en) * | 2021-11-30 | 2023-07-07 | 西北农林科技大学 | Truncated expressed Mandarin infectious spleen and kidney necrosis virus main capsid protein and application thereof |
CN116121197B (en) * | 2022-09-28 | 2023-10-20 | 华南农业大学 | Monoclonal antibody of anti-iridovirus SDDV isolate of yellow-fin sea bream and application thereof |
CN116004483B (en) * | 2023-03-09 | 2023-06-02 | 四川厌氧生物科技有限责任公司 | Lactococcus garvieae for preventing or treating diarrhea and application thereof |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0195792A (en) * | 1987-10-07 | 1989-04-13 | Sapporo Breweries Ltd | Novel substance 46nw-04a, production thereof and antiviral pharmaceutical containing said substance as active ingredient |
DK0382271T3 (en) | 1989-02-04 | 1995-05-01 | Akzo Nobel Nv | Tocoler as adjuvants in vaccines |
CN1290429C (en) * | 1997-03-21 | 2006-12-20 | 株式会社益力多本社 | Infectious disease preventive/remedy for fishes and shellfishes |
BR9916399A (en) | 1998-12-21 | 2001-09-11 | Akzo Nobel Nv | Method for preparing a vaccine aided by inactivated water / oil emulsion, and a set of parts that can be used for the preparation of a vaccine aided by inactivated water / oil emulsion |
SG144692A1 (en) * | 2000-09-15 | 2008-08-28 | Intervet Int Bv | Antigenic proteins of shrimp white spot syndrome virus and uses thereof |
CA2707919C (en) * | 2007-12-04 | 2014-02-11 | Schweitzer Co., Ltd. | A subunit vaccine for aquaculture |
CN101507774B (en) * | 2009-03-20 | 2010-12-01 | 宫玉泰 | Traditional Chinese medicine for treating ichthyosis |
WO2012130723A1 (en) * | 2011-03-25 | 2012-10-04 | Intervet International B.V. | Salmonid alphavirus vaccine |
-
2014
- 2014-05-28 AU AU2014273183A patent/AU2014273183B2/en active Active
- 2014-05-28 MY MYPI2015002848A patent/MY181007A/en unknown
- 2014-05-28 CN CN201910622924.8A patent/CN110438090B/en active Active
- 2014-05-28 WO PCT/EP2014/061014 patent/WO2014191445A1/en active Application Filing
- 2014-05-28 CN CN201480031056.1A patent/CN105247043A/en active Pending
- 2014-05-28 SG SG11201509830UA patent/SG11201509830UA/en unknown
Also Published As
Publication number | Publication date |
---|---|
CN105247043A (en) | 2016-01-13 |
SG11201509830UA (en) | 2015-12-30 |
CN110438090B (en) | 2023-12-05 |
AU2014273183A1 (en) | 2015-11-19 |
AU2014273183B2 (en) | 2017-01-19 |
CN110438090A (en) | 2019-11-12 |
WO2014191445A1 (en) | 2014-12-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MY181007A (en) | Scale drop disease (sdd) causative virus and derivatives thereof | |
CL2018001051A1 (en) | Nucleic acid vaccines against varicella zoster virus (vzv) | |
MX2021000435A (en) | Bispecific molecules that are immunoreactive with immune effector cells that express an activating receptor. | |
BR112017001579A2 (en) | anti-cd3 antibodies, activatable anti-cd3 antibodies, multispecific anti-cd3 antibodies, multispecific activatable cd3 antibodies and methods of use | |
CL2016001102A1 (en) | Novel anti-claudin antibodies and methods of use. | |
MX366275B (en) | Methods for detecting and measuring aggregation. | |
CL2015001266A1 (en) | Antihemagglutinin antibodies and methods of use. | |
MX350274B (en) | Vaccines for hsv-2. | |
AR091582A1 (en) | VACCINES ATTENDED AGAINST STREPTOCOCCUS SUIS AND METHODS OF ELABORATION AND USE OF THE SAME | |
BR112017009764A2 (en) | bispecific antibodies and methods of use in ophthalmology | |
EA201891124A3 (en) | NEW FLOURED ADJUVANTS AND DELIVERY SYSTEMS | |
MX2017008096A (en) | Pestivirus. | |
MY191539A (en) | Streptococcal vaccine | |
CL2012003458A1 (en) | Vector comprising a campylobacter antigenic polypeptide; pharmaceutical composition comprising said vector; use of the vector to improve the subject's immune response to the antigenic polypeptide. | |
BR112015003032A8 (en) | isolated antibodies, isolated nucleic acids, host cell, method of producing an antibody, immunoconjugate, pharmaceutical formulation, use of the antibody and method of treatment of an individual. | |
EP3212672A4 (en) | Methods and compositions for recombinant dengue viruses for vaccine and diagnostic development | |
EP3491386A4 (en) | Immunoassay methods and compositions for detecting infection involving use of test antigens as cross-reactive control antigens | |
MX2016013584A (en) | Porcine parvovirus. | |
EA201400216A1 (en) | CANNING OF BIOLOGICAL PRODUCTS, IN PARTICULAR VACCINES, WITH THE APPLICATION OF VACUUM | |
AR094810A1 (en) | PARVOVIRUS PORCINO 5B, METHODS OF USE AND VACCINE | |
EA201691091A1 (en) | DIAGNOSTIC REAGENTS FOR IMPROVED IN VIVO OR IN VITRO CELL-MEDIATED IMMUNOLOGICAL DIAGNOSTICS OF TUBERCULOSIS | |
MX2014015766A (en) | Toll-like receptors and immunostimulatory oligonucleotides. | |
ES2503516R1 (en) | IMMUNOGENIC COMPLEX FOR VACCINATION AND METHOD OF OBTAINING | |
WO2012114312A3 (en) | Exogenous internal positive control | |
BR112017003979A2 (en) | method for the preparation of a vaccine antigen, vaccine likely to be produced by the implementation of the method, and use of a calixeene |